Format

Send to

Choose Destination
Curr Eye Res. 2005 Jul;30(7):505-15.

A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs.

Author information

1
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. gordonsj@upmc.edu

Abstract

PURPOSE:

Antimicrobial peptides (AMPs) are an essential part of innate immunity that evolved in most living organisms over 2.6 billion years to combat microbial challenge. These small cationic peptides are multifunctional as effectors of innate immunity on skin and mucosal surfaces and have demonstrated direct antimicrobial activity against various bacteria, viruses, fungi, and parasites. This review summarizes their progress to date as commercial antimicrobial drugs for topical and systemic indications.

METHODS:

Literature review.

RESULTS:

Despite numerous clinical trials, no modified AMP has obtained Food & Drug Administration approval yet for any topical or systemic medical indications.

CONCLUSIONS:

While AMPs are recognized as essential components of natural host innate immunity against microbial challenge, their usefulness as a new class of antimicrobial drugs still remains to be proven.

PMID:
16020284
PMCID:
PMC1497874
DOI:
10.1080/02713680590968637
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center